***Background.*** Starting in April 2005, as part of our Antimicrobial Stewardship Program (ASP), prescribers were required to select an indication as part of an antimicrobial (AM) order; "other" was an option. In 2011, Centers for Medicare and Medicaid Service (CMS) added "antibiotic orders include an indication for use" as part of its surveyor worksheet. We initiated a daily review of active AM orders with "other" as the indication in April 2012. The goal of this project is to describe our two year experience with this process.

***Methods.*** Our hospital utilizes EPIC (Madison, WI) as our electronic health record (EHR). The on-call ID physician ran a daily report of active AM orders with indication other, reviewed the clinical record, and documented agreement or recommended interventions in the EHR. We performed a retrospective chart review to assess the acceptance of those recommendations.

***Results.*** During the study period, there were 43,384 AM orders, 18% had "other" as the indication. We reviewed 3851 orders with "other" as the listed indication of which 196 (5%) required interventions. There was variability in the acceptance rate by type of intervention:

                              Accepted Interventions   Percent Accepted         
  --------------------------- ------------------------ ------------------ ----- ----
  Add Antibiotic (10%)        19                       3                  86    14
  Stop Antibiotic (42%)       67                       29                 70    30
  Modify Therapy (43%)        72                       26                 73    27
  Recommend ID consult (3%)   5                        1                  83    17
  Recommend isolation (3%)    6                        0                  100   0

Multiple interventions were suggested in 12% of reviews. The recommended intervention was accepted 74% of the time. The acceptance rate was similar in ICU and non-ICU patient care settings.

We noted differences in ordering patterns by AM class. Fluoroquinolones comprised 2% of all AM orders which represented 9% of all indication "other" orders. This class made up 9% of our interventions. Nebulized tobramycin was 0.6% of total AM orders but 2.5% of orders with an "other" indication.

***Conclusion.*** 5% of all AM orders with indication "other" required an intervention, the majority of which were accepted. Some AM classes were overrepresented in the indication "other" orders but had a similar rate of intervention. This offers an opportunity to refine the approved indication list and provide additional prescriber education. In anticipation of a CMS requirement for AM indication, ASPs should carefully select preapproved indications for AMs.
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